# RNN 1st Gen Model Intuitive Surgical, Inc. Surgical appliances & supplies

Stock predictor AI models:
66.67% successful of 66 deals
$ 332.30 Last close price
at 18-oct-2021


Model's trade recommendations -6.54% Return for period

11.14% Annual return

$50.87B Market Cap

β 0.56  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period -6.54%
52wk return 20.94%
52wk Range
Sortino ratio 1.37
Sharpe ratio 0.40
Norm. RMSE 0.94%
Downside risk 12.11%
Volatility 0.00%
  • STRONG BUY Analysts consensus recommendation

Intuitive Surgical, Inc. is the global technology leader in minimally invasive robotic-assisted surgery. The Company's da Vinci Surgical System enables surgeons to operate minimally invasively through a few small incisions or the belly button from a nearby ergonomic console. The da Vinci System features a magnified 3D HD vision system and tiny wristed instruments that bend and rotate far greater than the human hand. As a result of this technology, da Vinci enables surgeons to operate with enhanced vision, precision and control.

Industry sector: Medical

Sector classification: Surgical appliances & supplies

Deep Learning based analysis and prediction model for Intuitive Surgical, Inc. (ISRG) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for ISRG model training are being downloaded from the Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for ISRG.

Model is being retrained on a daily basis.

Float 111M
P/E 51.35
Shares Outstanding 113M
% Held by Insiders 2.20%
% Held by Institutions 87.68%
EPS (last reported FY) $7.19
EPS (last reported Q) $2.44
EPS, estimated (last reported Q) $1.65
Total revenues $3 B
Net income $1 B